<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02078050</url>
  </required_header>
  <id_info>
    <org_study_id>2013-A00638-37</org_study_id>
    <nct_id>NCT02078050</nct_id>
  </id_info>
  <brief_title>Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures</brief_title>
  <official_title>Volontary Inspiratory Muscles Measures Compared With Phrenic Nerves Magnetic Stimulations Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory failure is the main death cause in neuromuscular diseases. Non-invasive and&#xD;
      volitional measures of inspiratory muscles strength include the nasal pressure with an&#xD;
      occluded nostril (Psnip) and the maximal inspiratory pressure (PImax). Unfortunately,&#xD;
      volitional maneuvers depend of patient effort. The aim of this research is to validate a&#xD;
      non-invasive and non-volitional technique to evaluate diaphragm strength at neuromuscular&#xD;
      diseases patients. The methodology consists to add to PImax and Psnip measures 5 phrenic&#xD;
      nerves magnetical stimulation maneuvers (Pstim).Stimulations will be realize at 3 inspiratory&#xD;
      pression levels (0, -1 cm H2O and -5 cm H2O).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">May 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Magnetic stimulation pressure measure (Pstim), according to 3 conditions : Pstime, Pstim-5 and Pstim-1 (measured in cmH20). The condition which is most correlated with maximal inspiratory pressure (Pimax or Psnip) is selected.</measure>
    <time_frame>10 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Neuromuscular Diseases</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Phrenic nerves magnetic stimulations</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phrenic nerves magnetic stimulations</intervention_name>
    <arm_group_label>Phrenic nerves magnetic stimulations</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old and more men or women&#xD;
&#xD;
          -  neuromuscular diseases&#xD;
&#xD;
          -  Pimax and Snip evaluation Indication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  Usual contre-indications for nuclear magnetic resonance&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hopital R. Poincar√©</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>December 20, 2013</study_first_submitted>
  <study_first_submitted_qc>March 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2014</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

